Fire, you are certainly entitled to your own opinion but not your own facts. The outstanding share count has remained relatively stable over the last few years, as Captain has stated.
In addition, here are a few more facts:
1. The company is currently doing over 10 million per quarter in revenue.
2. The company has essentially doubled in size(revenue and locations) over the last year.
3. The company is edging towards profitability in early 2020, as stated by the CEO. If you don't believe the CEO, then look at the numbers Jimmy Quick has posted multiple times (they are accurate), and you will see see profitability in the near future.
4, The company has 3 years of audited financials and should become SEC reporting in early 2020.
5. The company established a separate business enitity called RXMD Therapeutics and will begin selling their own CBD medical products in 2020.
6. The company has established a medication managment system, which assists providers meeting their performance citeria for third party
payers.
7. The company purchased a 12,000 square foot building (not sure of exact size) they are moving their Miami operation into next year. This will allow for further mail-order and manufacturing capabilities.
Now I can't change what you believe and I wouldn't try, but this company is not your typical OTC operation and those of us who have been here for years, know what potential the company has in its future.
Wolf